Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial
暂无分享,去创建一个
A. Okamoto | K. Ushijima | R. Coleman | S. Nagase | D. Aoki | H. Xiong | H. Kato | H. Takano | S. Nagao | M. Mizuno | Kimihiko Ito | S. Kamiura | M. Takekuma | H. Nakai | H. Tokunaga | M. Okadome | C. Ratajczak | Y. Nishimura | Noriyuki Katsumata | Takayuki Enomoto | H. Hashiba